Peripheral Blood CD14+ Monocytes from ATCC

Product Specs
ItemPeripheral Blood CD14+ Monocytes
CompanyATCC
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberPCS-800-010
TypePrimary Cell
Applications3D cell culture, Immunology, Toxicology, Immuno-oncology, Cell and gene therapy (CGT) development
Quantity1
Research Area3D cell culture, Immunology, Toxicology, Immuno-oncology, Cell and gene therapy (CGT) development
Cell Typemonocyte
GenderLot specific
AgeLot specific
Diseasenormal
SpeciesHuman
TissuePeripheral blood

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

(1) Harnessing the synergy of perfusable muscle flap matrix and adipose-derived stem cells for prevascularization and macrophage polarization to reconstruct volumetric muscle lossBioactive MaterialsApril 1, 2023Qixu Zhang, Yulun Chiu, Youbai Chen, Yewen Wu, Lina W. Dunne, Rene D. Largo, Edward I. Chang, David M. Adelman, Mark V. Schaverien, Charles E. Butlerand then biological analyses were performed. 2.4.1 Cell culture Normal human CD14+ M0 monocytes (PCS-800-010; ATCC, Manassas, VA) were cultured in phenol red–free RPMI-1640 supplemented with 10% fetal bovine serum,

(3) The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor BindingCell host & microbeJanuary 10, 2018King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, et al.

(4) Soybean peptide fractions inhibit human blood, breast and prostate cancer cell proliferationJournal of food science and technologyJanuary 1, 2017Rayaprolu SJ, Hettiarachchy NS, Horax R, Phillips GK, Mahendran M, Chen P.

Citations (4)